Quote:
Originally Posted by TLO
That makes sense - but with what I understand is a limited supply on hand, who makes the decisions on who gets it and who doesn't?
|
It depends. Pharmaceutical inventory and procurement isn't really my bag, but many newly-approved drugs with narrow uses are restricted to larger hospitals and the institutions that participated in the original study because the practitioners know the most about their use. Additionally, there are tight restrictions on who can prescribe.
About two years ago the FDA approved a reversal agent for Factor Xa inhibitors (like Xarelto or Eliquis if you'd seen the commercials) called Andexxa. It was about $30,000 for a treatment course and very difficult to obtain unless you got in on the ground floor.
__________________
"When the Know-Nothings get control, it will read 'all men are created equal, except negroes, and foreigners, and Catholics.' When it comes to this I should prefer emigrating to some country where they make no pretense of loving liberty – to Russia, for instance, where despotism can be taken pure, and without the base alloy of hypocrisy.”--Abraham Lincoln
|